Posted by Michael Wonder on 01 Jul 2025
Schedule of Pharmaceutical Benefits - 1 July 2025
1 July 2025 - The July 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The July issue of the Schedule includes has a few new/revised listings of note:
- Etanercept (Nepexto) - new biosimilar medicine
- Faricimab (Vabysmo) - new formulation
- Ivosidenib (Tibsovo) - new medicine
- Maribavir (Livtencity) - new medicine
- Nivolumab (Opdivo) - new indication
- Ribociclib succinate (Kisqali) - new indication
